Pioglityazone and Imatinib for CML Patients
NCT02888964
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Myeloid, Chronic-Phase
Interventions
DRUG:
Add-on therapy
Sponsor
Versailles Hospital